Contract facts
FederalNo full NAICS 334516 intel page yet. Browse NAICS intelligence
BENZODIAZEPINE REAGENT KITS is a federal award for W40m Mrco Pacific held by Microgenics Corp. Estimated value $156K ($156K obligated). Current period of performance ends Sep 23, 2025. Place of performance: FREMONT CA.
Recompete timing
PublicCurrent PoP ended Sep 23, 2025 (332 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordMicrogenics Corp — $4.3M obligated across 166 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract W81K0225FA049?
W81K0225FA049 (Benzodiazepine reagent KITS) is a W40m Mrco Pacific award with a potential value of $156K, currently held by Microgenics Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded W81K0225FA049?
W40m Mrco Pacific awarded W81K0225FA049 to Microgenics Corp (potential $156K).
Who is the incumbent on W81K0225FA049?
Microgenics Corp is the incumbent with $4.3M across 166 related awards in SCOUT’s public footprint. The current period of performance ends Sep 23, 2025.
When does Microgenics Corp’s W81K0225FA049 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 23, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
